SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
1824554
Source:
http://linkedlifedata.com/resource/pubmed/id/1824554
Search
Subject
(
66
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003962
,
umls-concept:C0016360
,
umls-concept:C0020433
,
umls-concept:C0039082
,
umls-concept:C0135096
,
umls-concept:C0205474
,
umls-concept:C0239981
,
umls-concept:C1555266
,
umls-concept:C1709059
pubmed:issue
12
pubmed:dateCreated
1991-12-23
pubmed:abstractText
To report a new syndrome of ascites, hyperbilirubinemia, and hypoalbuminemia after treatment with N-phosphonacetyl-L-aspartate (PALA) and fluorouracil for metastatic colorectal cancer.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/P01-CA-25842
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1824554-1530700
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372351
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Aspartic Acid
,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil
,
http://linkedlifedata.com/resource/pubmed/chemical/NSC 224131
,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphonoacetic Acid
,
http://linkedlifedata.com/resource/pubmed/chemical/Serum Albumin
,
http://linkedlifedata.com/resource/pubmed/chemical/Transaminases
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0003-4819
pubmed:author
pubmed-author:CostaPP
,
pubmed-author:KemenyNN
,
pubmed-author:KurtzR CRC
,
pubmed-author:MartinDD
,
pubmed-author:MurrayMM
,
pubmed-author:NiedzwieckiDD
,
pubmed-author:SeiterKK
,
pubmed-author:UrmacherCC
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
115
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
946-51
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:1824554-Aged
,
pubmed-meshheading:1824554-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:1824554-Ascites
,
pubmed-meshheading:1824554-Aspartic Acid
,
pubmed-meshheading:1824554-Colorectal Neoplasms
,
pubmed-meshheading:1824554-Drug Evaluation
,
pubmed-meshheading:1824554-Fluorouracil
,
pubmed-meshheading:1824554-Humans
,
pubmed-meshheading:1824554-Hyperbilirubinemia
,
pubmed-meshheading:1824554-Liver Neoplasms
,
pubmed-meshheading:1824554-Male
,
pubmed-meshheading:1824554-Phosphonoacetic Acid
,
pubmed-meshheading:1824554-Prothrombin Time
,
pubmed-meshheading:1824554-Retrospective Studies
,
pubmed-meshheading:1824554-Serum Albumin
,
pubmed-meshheading:1824554-Syndrome
,
pubmed-meshheading:1824554-Transaminases
pubmed:year
1991
pubmed:articleTitle
A new syndrome: ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA)
pubmed:affiliation
Memorial Sloan-Kettering Cancer Center, New York, New York.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, U.S. Gov't, P.H.S.
,
Case Reports